Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2026 Apr 21;17:1827794. doi: 10.3389/fphar.2026.1827794

Correction: Naoxintong capsule decreases circulating exosomes of miR-382-5p to protect LPS-induced vascular endothelial cell injury by targeting STC1 in vitro

Ziyan Xu 1, Hao Wu 1, Weiyang Fan 1, Fenzhao Meng 1, Shuangfei Hu 1, Muhan Zou 1, Yixuan Chen 1, Weiwei Su 1, Peibo Li 1,*
PMCID: PMC13139907  PMID: 42093883

In the original publication, there were a few mistakes in Figures 1, 2, 7, 8. In Figure 1D, the kDa value for the protein ALIX was incorrectly stated as “80” instead of the correct “96”. In Figure 2G, the kDa value for the protein Cleaved caspase 3 was incorrectly stated as “23” instead of the correct “17”. In Figure 7I, the kDa value for the protein Cleaved caspase 3 was incorrectly stated as “16” instead of the correct “17”. In Figure 8H, the kDa value for the protein Cleaved caspase 3 was incorrectly stated as “23” instead of the correct “17”. The corrected Figures 1, 2, 7, 8 appear below.

FIGURE 1.

Panel A displays a line graph comparing average weight over seven days between control and NXT groups, showing similar increasing trends. Panel B presents electron microscopy images of Ctl-Exo and NXT-Exo exosomes, highlighting their morphology. Panel C shows size distribution graphs of exosomes for both groups, with sharp peaks indicating size range. Panel D features western blot bands for exosome markers ALIX, TSG101, and CD9, demonstrating their presence in Ctl-Exo and NXT-Exo samples. Panel E is a bar graph showing a significantly higher exosome concentration in the NXT-Exo group compared to Ctl-Exo. Panel F displays fluorescence microscopy images of cells treated with Ctl-Exo and NXT-Exo, labeling exosomes in red, nuclei in blue, and membranes in green, with a merged image illustrating colocalization.

Body weight map and biological identification, concentration determination, and internalization of circulating exosomes. (A) Daily body weight of SD rats during the experiment. (B) Circulating exosomes scanning results of TEM (Scale bar, 50 nm). (C) The particle diameter distribution of circulating exosomes tested by NTA. (D) The circulating exosome markers (ALIX, TSG101, CD9) and the negative control marker (β-actin) detected by Western blot. (E) The concentrations of circulating exosomes tested by BCA. (F) The internalization of circulating exosomes from SD rats in HMEC-1 imaged by confocal microscopy (Scale bar, 10 μm). PKH-26 (Ex: 551 nm, Em: 562∼580 nm) labeled circulating exosomes, Dio (Ex: 484 nm, Em: 496∼520 nm) labeled cell membrane, and Hoechst 33342 (Ex: 346 nm, Em: 455∼470 nm) labeled cell nuclei. Values are expressed as mean ± SD, n = 3. * p < 0.05, ** p < 0.01 and ns indicated no significant statistical difference.

FIGURE 2.

Multi-panel scientific figure showing quantitative results from cell viability assays, nitric oxide and protein measurements, flow cytometry analysis, and western blots. Panels A-E present bar graphs of cell viability, extracellular NO, eNOS, and ET-1, with significant differences indicated by asterisks between treatment groups (NC, LPS, LPS+Ctl-Exo, LPS+NXT-Exo). Panel F shows flow cytometry dot plots and a corresponding apoptosis rate bar graph for each group. Panel G displays western blots detecting Bcl-2, Bax, Cleaved caspase 3, and β-actin, along with quantification bar graphs, comparing protein expression across experimental conditions.

NXT-Exo inhibited LPS-induced HMEC-1 dysfunction and apoptosis. (A) The cell viability of HMEC-1 after LPS stimulation were detected by CCK-8 assay. (B) The effects of NXT-Exo on the cell activity of HMEC-1 induced by LPS were detected by CCK-8 assay. (C–E) The expression levels of NO, eNOS and ET-1 in HMEC-1 were measured by ELISA. (F) The apoptosis rates of HMEC-1 were detected by flow cytometry. The horizontal axis B525-A corresponds to the detection of Annexin V staining (Ex = 494 nm, Em = 518 nm), and the vertical axis B610-A corresponds to the detection of PI staining (Ex = 535 nm, Em = 617 nm). (G) The relative protein expression levels of Bax, Bcl-2 and Cleaved caspase 3 were detected by Western blot. Values are expressed as mean ± SD, n = 3. * p < 0.05 and ** p < 0.01.

FIGURE 7.

Eight bar graphs labeled A to H and a Western blot panel labeled I compare molecular and cellular markers among experimental groups, showing significant differences in gene expression, cytokine levels, and oxidative stress markers, with error bars and significance indicated by asterisks.

miR-382-5p downregulated the expression of STC1 and the effect of STC1 on the endothelial protection of NXT-Exo. (A) The mRNA expression level of STC1 in HMEC-1 transfected with miR-382-5p mimic or miR-382-5p mimic-NC was detected by RT-qPCR. (B) The mRNA expression level of STC1 in HMEC-1 treated with NXT-Exo or NXT-Exo combined with miR-382-5p was detected by RT-qPCR. (C) The transfection of si-STC1 was verified by RT-qPCR. (D,E) The secretion levels of IL-6 and IL-8 were measured by ELISA. (F) The release of LDH was detected by microplate method. (G,H) The production level of ROS and expression level of MDA were tested by fluorescence. (I) The effects of miR-382-5p and STC1 treatment on the relative protein expression levels of Bax, Bcl-2, Cleaved caspase 3 and STC1 in HMEC-1 were detected by Western blot. Values are expressed as mean ± SD, n = 3. * p < 0.05, ** p < 0.01.

FIGURE 8.

Panel A shows fluorescent microscopy images of cells labelled for exosomes (red), nuclei (blue), and membrane (green) with merged views for Ctl-Exo and NXT-Exo conditions. Panels B–F present bar graphs quantifying cell viability, extracellular NO, eNOS, and ET-1 under various treatments, with significance indicated. Panel G displays flow cytometry scatter plots and a bar chart for apoptosis rates under different treatments. Panel H shows western blot bands and quantification graphs for Bcl-2, Bax, and cleaved caspase 3 expression in each condition, with β-actin as a loading control.

NXT-Exo inhibited LPS-induced HUVEC dysfunction and apoptosis. (A) The internalization of circulating exosomes from SD rats in HUVEC imaged by confocal microscopy (Scale bar, 10 μm). PKH-26 (Ex: 551 nm, Em: 562∼580 nm) labeled circulating exosomes, Dio (Ex: 484 nm, Em: 496∼520 nm) labeled cell membrane, and Hoechst 33342 (Ex: 346 nm, Em: 455∼470 nm) labeled cell nuclei. (B) The cell viability of HUVEC after LPS stimulation were detected by CCK-8 assay. (C) The effects of NXT-Exo on the cell activity of HUVEC induced by LPS were detected by CCK-8 assay. (D–F) The expression levels of NO, eNOS and ET-1 in HUVEC were measured by ELISA. (G) The apoptosis rates of HUVEC were detected by flow cytometry. The horizontal axis B525-A corresponds to the detection of Annexin V staining (Ex = 494 nm, Em = 518 nm), and the vertical axis B610-A corresponds to the detection of PI staining (Ex = 535 nm, Em = 617 nm). (H) The relative protein expression levels of Bax, Bcl-2 and Cleaved caspase 3 were detected by Western blot. Values are expressed as mean ± SD, n = 3. * p < 0.05, ** p < 0.01.

The original article has been updated.

Footnotes

Edited and reviewed by: Wei Peng, Chengdu University of Traditional Chinese Medicine, China

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES